Journals / Turkish Journal of Hematology / 2007 / Cilt: 24 - Sayı: 3

Yenidoğan yoğun bakım ünitesinde trombositoz: Tek merkezin deneyimi

Thrombocytosis in the neonatal intensive care unit: Experience at a single center

Pages
110–116
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In light of associated disorders, the mechanism of thrombocytosis in newborns may differ from that of childhood thrombocytosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although thrombocytosis is frequently detected in newborns, few reports have focused on its risk factors.
📊
Key Findings & Data:This report documents the characteristics of 89 neonates with thrombocytosis followed up in a neonatal intensive care unit (NICU).
💡
Conclusion & Impact:In light of associated disorders, the mechanism of thrombocytosis in newborns may differ from that of childhood thrombocytosis.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Yoğun bakım üniteleri · yenidoğan · Trombositoz

Abstract

Although thrombocytosis is frequently detected in newborns, few reports have focused on its risk factors. This report documents the characteristics of 89 neonates with thrombocytosis followed up in a neonatal intensive care unit (NICU). We reviewed the patients' medical and laboratory records retrospectively to determine the associated conditions and risk factors for neonatal thrombocytosis, and complications related to thrombocytosis- We also discussed the differences of neonatal thrombocytosis from that of childhood in the light of literature. The mean platelet count of these newborns was 579,7 ±111.5 (451-936) x 109/L Associated conditions included anemia (73.7%), high-risk pregnancies (56. %), prematurity (51.7%), infections (37.1%), antenatal drug use (22.7%), indirect hyperbilirubinemia (20.2%), cardiac disorders (14.6%), respiratory distress syndrome (14.6%), history of hypoxia (13.5%), surgery (12.4%), and hemorrhage (3.4%). In most cases, more than one risk factor for thrombocytosis existed in the same newborn. No hemorrhagic complications related to thrombocytosis were observed; however, 1 newborn had portal vein thrombosis associated with intestinal malrotation. In summary, risk factors and associated conditions for thrombocytosis in newborns differed from those in children. In light of associated disorders, the mechanism of thrombocytosis in newborns may differ from that of childhood thrombocytosis.

Özet

Bu yenidoğânlârın ortalama trombosit sayıları 579.7 ± 111.5 (451-936) x 109A idi. Trombösitozla birlikte bulunan tıbbi durumlar şöyleydi: %73.7 anemi, %56.2 yüksek riskli gebelik, 9651.7 premâtürite, %37.1 infeksiyonlar, %22.7 antenatal ilaç kullanımı, %20.2 indirekt hİperbilirubinemi, %14.6 kardlyâk hâstaliklar, %14.6 respiratuar distres hastalıkları, %13.5 hipoksi hikayesi, %İ2.4 ameliyat, %3.4 herrioraji. Olguların çoğunda aynı yenidoğahda birden fazla risk faktörü buiundu. Trombosİtoza bağiı hemörajik bir kompiikasyon görülmezken, sâdece bir yenidöğanda intestinal lîıalrotâsyöna bağlı portal ven trömbozu mevcuttu. Sonuç olarak, yenidoğan trombositozuyla birlikte bulunan tıbbi durumlar ve risk faktörlerinin çocukluk yaş grubundan farkli olduğu bulundu.

🔖

Cite This Article

ÖZYÜREK, E., TARCAN, A., YAPRAKCI, E., TOKEL, K., GÜRAKAN, B., ÖZBEK, N. (2007). Yenidoğan yoğun bakım ünitesinde trombositoz: Tek merkezin deneyimi. Turkish Journal of Hematology, Cilt: 24 - Sayı: 3, 110–116. https://ajindex.com/articles/413023

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Christensen RD. Expected hematologic values for term and preterm neonates. In: Christensen RD, editor. Hematologic Problems of the Neonate. 2n d ed. Philadelphia: WB Saunders, 2000:117-36
  2. Schafer AI. Thrombocytosis and thrombocythemia. Blood Rev 2001; 15:159-66
  3. Heng JT, Tan AM. Thrombocytosis in childhood. Singapore Med J 1998;39:485-7
  4. Heath HW, Pearson HA. Thrombocytosis in pediatric outpatients. J Pediatr 1989; 114:805-7
  5. Chan KW, Kaikov Y, Wadsworth LD. Thrombocytosis in childhood: A survey of 94 patients. Pediatrics 1989;84:1064-7
  6. Lilleyman JS, Vora AJ. Secondary thrombocytosis. Arch Dis Child 1993;68:88-90
  7. Yohannan MD, Higgy KE, al-Mashhadani SA, Santosh Kumar CR. Thrombocytosis. Etiologic analysis of 663 patients. Clin Pediatr (Phila) 1994;33:340-3
  8. Matsubara K, Fukaya T, Nigami H, Harigaya H, Hirata T, Nozaki H, Baba K. Age-dependent changes in the incidence and etiology of childhood thrombocytosis. Acta Haematol 2004;lll:132-7
  9. Sola MC, Christensen RD. Developmental aspects of platelets and disorders of platelets in the neonatal period. In: Christensen RD, editor. Hematologic Problems of the Neonate. 2n d ed. Philadelphia: WB Saunders, 2000:117-36
  10. Donate H, Vain N, Rendo P, Vivas N, Prudent L, Larguia M, Digregorio J, Vecchiarelli C, Valverde R, Garcia C, Subotovsky P, Solana C, Gorenstein A. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics 2000;105:1066-72
  11. Ikeno K, Koike K, Takeshita A, Shinjo K, Higuchi T, Nakabayashi T, Akanuma S, Hizume K, Ishiguro A, Ogami K, Kato T, Miyazaki H, Ohno R, Komiyama A. Stressful delivery influences circulating thrombopoietin (TPO) levels in newborns: possible role for cortisol in TPO-mpl binding. Early Hum Dev 2000;58:225-35
  12. Gupta G, Gupta I, Suri V, Dhawan V, Ganguly NK. Estimation of cord blood erythropoietin in pre-eclampsia and eclampsia. Int J Gynecol Obstect 2000;71:l-5
  13. Teramo K, Kari MA, Eronen M, Markkanen H, Hiilesmaa V. High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologica 2004;47:1695-703
  14. Miller CP, Liu ZY, Noguchi CT, Wojchowski DM. A minimal cytoplasmic subdomain of the erythropoietin receptor mediates erythroid and megakaryocytic cell development. Blood 1999;94:3381-7
  15. Ozsoylu S, i